TAVR-30
Risk assessment tool
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today

Description

Patients undergoing transcatheter aortic valve replacement (TAVR) are at a higher risk of recurrent healthcare resource utilization due to multiple comorbidities, frailty, and advanced age. The 30-day all-cause readmission rate has been reported at 15-20%. We have devised a simple tool to identify patients at higher risk of 30-day readmission using the Nationwide Readmissions Databases (from January 2013 to September 2015).

This simple and easy-to-use risk prediction tool may help identify TAVR patients at increased risk of 30-day readmission, and aid in appropriate transition of care upon discharge and post-discharge follow-up.

Note: This app (“App)” provides only information, is not medical or treatment advice and may not be treated as such by the user. As such, this App may not be relied upon for the purposes of medical diagnosis or as a recommendation for medical care or treatment. The information on this App is not a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images and information, contained on or available through this App is for general information purposes only
Hide.. Show more..

Screenshots

User Rating

0 out of 5

0 ratings in New Zealand

Ratings History

Reviews

App doesn't have any reviews yet

Store Rankings

Ranking History

App Ranking History not available yet

Category Rankings

App is not ranked yet

Keywords

Users may also like

Name
Cathlas
Coronary Angiography Atlas
Valve In Valve
ManageMR
Aortic surgery guidelines
N/A/
N/A/
Valve PPM
VIVID Calculator
TAVR Sizing App
MCSAID
3mensio Report
Show More

Revenue and Downloads

Gain valuable insights into TAVR-30 performance with our analytics. Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
Ankur Kalra
Languages
English
Recent version
2.0 (4 years ago )
Released on
Sep 23, 2018 (5 years ago )
Last updated
2 months ago